Ribupatide
KaiNETIC-2
Fujian Shengdi Pharmaceutical Co · Phase 3 · Active, not recruiting · Enrollment 1270
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Ribupatide: Dose 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Ribupatide: Dose 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Ribupatide: Dose 3 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Ribupatide: Dose 4 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |